Skip to main content
 This program is not active.

S24-105 Update of Psychopharmacology for Youth with Mental Health Disorders

Total Credits: 3 including 3 Category I CEs

100 Children & Adolescents
Jason Noel PharmD, BCPP
Course Levels:
3 Hours 15 Minutes
Target Audience:
Social Workers, LCPCs, and Psychologists



 It is estimated that about 17% of youth experience a mental health disorder.  Psychotropic drugs are a widely used modality to manage symptoms and improve functioning in this population.  While they may be very effective, they may carry significant short- and long-term risks.  Patients, family members, and advocates all play a key role in ensuring safe and effective treatment with psychotropic drugs.  This seminar will provide an overview of the drug classes used to treat behavioral health disorders in youth and identify strategies to mitigate treatment risks.



Jason Noel PharmD, BCPP Related Seminars and Products

Dr. Jason Noel received his Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees at Rutgers University College of Pharmacy.  He completed a residency in Psychiatric Pharmacy Practice at the University of Maryland School of Pharmacy. He later obtained a Master of Public Administration from the University of Baltimore. He is a Board-Certified Psychiatric Pharmacist. Dr. Noel’s clinical practice focus is mental health and intellectual/developmental disabilities. He teaches therapeutics of psychiatric and neurologic disorders in UMB’s Pharm.D. and Nursing graduate programs, as well as to audiences of training and practicing clinicians, including pharmacists, physicians, physician assistants, nurses, and social workers.   

Agenda & Learning Objectives


1:00 – 1:15 Registration / Log-On 

1:15 – 2:45  

  • Drug Class Overview 

    • Stimulants and Nonstimulants 

    • Antidepressants 

    • Mood Stabilizers 

    • Antipsychotics 

    • Antianxiety Agents 

2:45 – 3:00 Break 

3:00 – 4:30  

  • Treatment Controversies 

    • Antidepressants and Suicidality 

    • ADHD and Substance Use Disorder 

    • Metabolic Syndrome 

  • Combining Behavioral and Psychosocial Treatments 

    • ADHD 

    • Major Depression 

    • OCD 

4:30 Questions and Adjournment 



Upon the completion of this workshop, participants will be able to.

  1. Identify by generic name, trade name, and pharmacologic class, the drugs used in the treatment of psychiatric disorders in youth, including attention-deficit/hyperactivity disorders, mood disorders, anxiety disorders, psychotic disorders, and neurodevelopmental disorders.
  2. Explain the expected outcomes of treatment with psychotropic drugs in youth.
  3. Describe common side effects of psychotropic drugs in youth and the common strategies used to minimize them.

Bibliography & References


Doyle CA, McDougle CJ. Pharmacotherapy to control behavioral symptoms in children with autism. Expert Opin Pharmacother. 2012;13(11):1615-29.

Lee ES, Kronsberg H, Findling RL. Psychopharmacologic Treatment of Schizophrenia in Adolescents and Children. Child Adolesc Psychiatr Clin N Am. 2020;29(1):183-210.

Wolrach ML, Hagan JF, Allan C, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics 2019;144(4) :e20192528

Vaughan B, Kratochvil CJ. Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2012;21(4):941-55.

Selph SS, McDonagh MS. Depression in Children and Adolescents: Evaluation and Treatment. Am Fam Physician. 2019;100(10):609-617.


Course Completion & CE Information

Category I Maryland BSWE Requirement

The Office of Continuing Professional Education at the University Of Maryland School Of Social Work is authorized by the Board of Social Work Examiners in Maryland to sponsor social work continuing education programs. This workshop qualifies for 3 Category I Continuing Education Units . The Office of Continuing Professional Education is also authorized by the Maryland Board of Psychologists and the Maryland Board of Professional Counselors to sponsor Category A continuing professional education.

Please refer to the tab "Live Interactive Webinar Policies & FAQs" for UMSSW Office of CPE policies regarding all live interactive webinar related matters.

Target Audience

Social Workers, LCPCs, and Psychologists

All those interested in Topic Welcomed

Late Fees and Refunds

Fee & Registration:

Cost is $70 and includes CE credit. Registering after 4/25/24 will incur an additional $20 late fee. *Cancellations must be received 24 hours in advance prior to the live interactive webinar to receive a refund or a credit letter.

*All cancellations will be subjected to a $35.00 administration fee

Live Interactive Webinar Platforms




The Office of Continuing Professional Education hosts Live Interactive Webinars through two platforms: Zoom and WebEx.

Both platforms offer high quality and user-friendly webinar platforms for our registrants.


System Requirements:

  • Operating Systems: Windows XP or higher; MacOS 9 or higher; Android 4.0 or higher.
  • Internet Browser: Google Chrome; Firefox 10.0 or higher.

Our system is not compatible with the Safari web browser.

  • Broadband Internet Connection: Cable, High-speed DSL and any other medium that is internet accessible.

**Please have your device charging at all times to ensure that your device does not lose power during the webinar.


Course Interaction Requirements:

To participate in Live Interactive Webinars, you MUST have a device that allows you to view the presentation on screen and hear the instructor at all times. We do not allow participants to call-in from their phones or mobile devices and solely listen to the presentation. Participation in Live Interactive Webinars is mandatory.

Webinar Policies & FAQs

Click The Link to View The Webinar Policies & FAQs



ADA Accommodations

If you are requesting ADA accommodations, please contact our office via email at least two weeks prior to the workshop date. Requests after that date may not be fulfilled.  

Our email address is